Skip to main content

Patient-reported side effects and satisfaction of pre-hospital analgesia with low-dose esketamine: a cross-sectional study

Abstract

Background

Analgesia is a core intervention in emergency medicine. Pain is subjective, so patient-reported experience with pain and analgesia is essential for healthcare professionals.

The aim of this study was to evaluate patient-reported side effects and satisfaction associated with pre-hospital analgesia with low-dose esketamine.

Methods

This is an observational cross-sectional study conducted as part of quality assurance measures of the German Red Cross Emergency Medical Service, Reutlingen, Germany.

The survey was administered to all patients who received prehospital esketamine analgesia from paramedics. Addresses were obtained from medical records and mailed 10 days after the event. Patient feedback was anonymous and could not be linked to operational documentation.

Results

A total of 201 patients were contacted, and 119 responses were received via the online questionnaire and postal mail (response rate 59%). The mean age of the patients was 68±13 years, with 64.7% (n=77) being female. The main diagnosis reported was fractures of the extremities in 69.7%. Patients reported initial median pain intensity on a Numeric Rating Scale (NRS) of 10 [8-10]. Pain was unbearable for 96.3% of patients. After administration of analgesia, 95.3% were satisfied or very satisfied. Patients reported no side effects in 78.5%, minor side effects in 10.0%, significant but well tolerable side effects in 11.3%, borderline tolerable side effects in 0.2%, and no unbearable side effects. Borderline tolerable nausea was reported in 2% of patients along with dreams in 0.8%. No nightmares were reported. Further analysis showed that patients older than 80 years reported significantly more side effects (p < 0.001) and were thus less satisfied with the analgesia.

Conclusions

Both patient perception and analgesia with few side effects were important for both safety and satisfaction. In the present study, low-dose esketamine analgesia was associated with low side effects and high patient satisfaction.

Peer Review reports

Background

Analgesia is one of the most significant interventions in emergency medicine. Characteristics such as rapid onset, short-acting effect, good safety profile with few side effects are important from the perspective of patients and professionals [1, 2]. However, studies show that there are difficulties in pain assessment and that analgesia itself is inadequate and thus unsatisfactory for patients [3]. There are many reasons for this, both on the part of the practitioner and the patient [4]. For successful analgesia, it is therefore important to consider the patient's needs and involve them in the decision-making process, in addition to providing trustworthy patient care [5].

In addition, analgesia is dependent on the analgesic used. The most common analgesics in German (prehospital) emergency medicine are fentanyl, morphine, and (es-)ketamine, as well as sufentanil and metamizole [6, 7]. Piritramide and inhaled analgesics, on the other hand, are recently gaining ground in emergency medical service [8, 9].

Ketamine plays a special role here, as its effect is dose dependent. At low doses, esketamine is an analgesic; at higher doses, it causes dissociative anesthesia to an extent. The transition from analgesia to anesthesia depends on dosage, co-medication, and patient condition, among other factors. For ketamine analgesia, dysphoria, vivid hallucinations, and even "emergence phenomena" (or agitation) are consistently reported as side effects; fewer reports are available for esketamine, the S-enantiomer of ketamine [1]. Esketamine has its main effect primarily by blocking NMDA (N-methyl-D-aspartate) receptors and partially binds to the opiate receptor, with cardiovascular stimulation by catecholamine release, inhibiting peripheral reuptake of catecholamines, and central sympathetic stimulation.

The importance of the pharmacological quality of the drugs on the one hand, but especially the patients' perception of analgesic efficacy with low side effects is crucial for successful analgesia and high patient satisfaction. Particularly for low-dose esketamine, it is unclear how pronounced the side effects are and how much they interfere with patient satisfaction [6].

Objectives

The aim is to assess the satisfaction and the side effects reported by the patients associated with analgesia with low-dose ketamine in a prehospital setting.

Methods

Study design

This is an observational cross-sectional survey study conducted as part of quality assurance measures of the German Red Cross Emergency Medical Service, Reutlingen, Germany. The reporting structure follows the Checklist for Reporting Of Survey Studies (CROSS) [10].

Setting

Since 2005, the Emergency Medical Service (EMS) in Reutlingen qualified and authorized its paramedics in a competence system for the independent administration of esketamine analgesia according to the specifications of the medical director. Indications for esketamine include all moderate to severe pain (NRS ≥ 5, trauma-associated pain, low back pain, and abdominal pain) [11,12,13]. This advanced delegation is deemed appropriate training, standard operating procedure (SOP), along with annual competence checks [14]. Emergency medical services in Germany are organized by the state and are operationally dependent on the federal state and county. In addition to paramedics, who are trained for three years, it is also possible to send an emergency physician (doctor in training or specialist) to the scene of an emergency by air or ground in case of defined indications.

Low-dose esketamine analgesia in the studied EMS included the administration of esketamine (Esketamin Inresa® 50mg/2ml) at an initial dose of 0.125 mg/kg body weight i.v. associated to 1 mg of intravenous midazolam (Midazolam Ratiopharm®, 5mg/5ml). Midazolam may be given once for dreams, psychomotor agitation, etc. Esketamine may be repeated as needed (inadequate pain relief, recurrent pain). Other analgesics have not been used.

Questionnaire

Validated pain questionnaires exist mainly for chronic pain conditions (e.g., FQ-STAPM, DSF, etc.) [15, 16]. General patient satisfaction surveys, using validated questionnaires, are also available [17, 18], although surveys of pain perception and analgesia are less common [19, 20].

A good template has already been created by the working group of Sander et al. [20]. However, they focus more on satisfaction and less on side effects, so we developed our own questionnaire (Supplementary file). Question types used were binary response fields (e.g. bearable pain: yes/no), four-point scales (e.g. no pain, mild pain, moderate pain, severe pain) and eleven-point scales (e.g. Numeric Rating Scale 0-10), and an open field was used for general comments. We conducted nine pretests with four nonmedical citizens and five patients from the specified target population to optimize the questionnaire and test its comprehensibility.

Data collection

The following data were collected: age, sex, previous experience with pain, pain assessment, patient-reported indication for analgesia, analgesia success, and incidence of side effects (Supplement questionnaire). The categories of side effects were developed based on various publications on esketamine analgesia and were classified as "no side effect, minor side effects, significant but well tolerable side effects, borderline tolerable side effects, unbearable side effects".

The pain-experience was measured with an endpoint named scale ranging from 0=no pain experience to 10=subjectively maximum pain experience.

Postal addresses were extracted from medical records and mailed 10 days after the event. In addition to the information text, the addressees received a paper questionnaire with a stamped return envelope and the option to complete the questionnaire online via a QR code. Patient feedback was anonymous and could not be linked to the operation or operation documentation or to specific patient data such as age, sex, body weight, or specific drug dosages.

Sample characteristics

All patients who received esketamine with analgesia, administered by paramedics in the German Red Cross Emergency Medical Service of Reutlingen, Germany between June 02, 2022, and November 28, 2022, were included. There were no exclusion criteria given the inclusion criteria. For data collection, patients were contacted per mail 10 days after the event.

Survey administrations

Questionnaires answered online via QR code were entered using Microsoft Forms. Multiple entries could not be intercepted. Postal returns were scanned using the optical character recognition software FormPro 3.1 (OCR-Systeme GmbH, Leipzig, Germany) and recorded as a dataset, with the correct composition and processing manually checked against the postal returns.

Study preparation

This survey was preceded by various analyses of routine and quality assurance data, feedback from emergency physicians, paramedics and emergency department staff, and most importantly, feedback and interviews with patients.

Statistical analysis

Descriptive statistics were reported with the metric scale for mean ± standard deviation (SD) when normally distributed or medians and interquartile range (IQR) when not normally distributed. Pearson's coefficient was used to describe correlations between metric variables. Frequencies are indicated with absolute and relative numbers. Two-tailed values of p < 0.05 were considered statistically significant. The χ2-test and, for independent samples with normally distributed data, the t-test or single-factor analysis of variance were used to calculate differences, or Mann-Whitney-U-Test when not normally distributed. Statistical analyses were performed with SPSS Statistics 28 (IBM, Armonk, NY, USA).

Results

A total of 201 patients were contacted, with 119 responses received via online questionnaire and postal mail (response rate 59%). The mean age was 68 ± 13 years (range 12-87 years). 64.7% (n=77) of patients were female. The questionnaire was completed by 68.9% (n=82) of respondents, and 31.1% (n=37) completed by their relatives. When asked about their previous experience with physical pain with the question “How 'experienced' are you with severe physical pain, e.g., major injuries, illnesses, tumors, surgeries, or therapies? Ranked from "no pain experience" to "most severe pain experience" (e.g., kidney colic and severe injuries)” the mean response was 5.1 ± 2.5 on an 11-point Likert scale, which is a medium pain experience and interviewed patients obviously have quite painful experiences.

Side effects of analgesia

Patients reported no side effects in 78.5%, minor side effects in 10.0%, significant but well tolerable side effects in 11.3%, borderline tolerable side effects in 0.2%, and unbearable side effects in 0% during low-dose analgesia with esketamine. Borderline tolerable side effects were nausea in 2%, followed by dreams in 1%. Significant but well tolerated side effects were restlessness in 25%, anxiety in 23%, palpitations and dyspnea in 16%. Dreams were also a significant but well-tolerated side effects in 13%. The three most frequent minor side effects were dreams in 19%, followed by nausea in 17% and blurred vision in 16%. The most common significant but tolerable side effect was restlessness with 25% (Fig. 1).

Fig. 1
figure 1

Frequencies of side effects reported. The graph shows the side effects on the x-axis and their frequency in % on the y-axis

Analysis showed that patients ≥ 80 years reported significantly more side effects (p<0.001) (Fig. 2).

Fig. 2
figure 2

Patient-reported side effects in relation to age groups. If the severity (0=no side effects to 4= unbearable side effects) of the 12 side effects were summed, a total score between 0 and 48 would be possible. This shows that the age group <50 years reported no side effects, the age group 50-59 years was not represented, the age group 60-69 years had a median score of 0.5 [0-1.5], and the age group 70-70 years had a median score of 0 [0-2]. In contrast, the oldest age group, 80-89 years, had a median score of 5 [4-16]

Indication and pain assessment

Fractures were the cause of pain and the indication for administration of analgesia in 69.5% of patients. Not all reported indications for analgesia were obvious, such as dyspnea (n=6, 5.1%) (Table 1).

Table 1 Reported indication for analgesia

Patients reported initial median pain on an NRS of 10 [8-10] (range 5-10). The additional question of whether the pain was considered tolerable prior to treatment was answered in the negative by 96.3%. When asked hypothetically if they could sleep with the pain, 96.6% (n=115) answered no. On a four-point pain scale (no pain, slight pain, moderate pain, severe pain), 6.5% (n=7) of patients reported moderate pain and 93.5% (n=101) of patients reported severe pain. Patients in the "moderate pain" group reported a median pain NRS of 6 [5-7], while patients in the "severe pain" group reported a median pain NRS of 10 [8-10]. A total of 104 patients (92.9%) received additional analgesia in the hospital. Following the administration of analgesia in the prehospital setting, 95.3% of patients were satisfied or very satisfied.

Pain experience was significantly correlated with increasing patient age (r=0.674, p<0.001). A correlation between "pain experience" and initial pain on the NRS could not be shown (r=0.030, p=0.758). When comparing the pain rating in function of the gender, female patients reported a higher NRS compared to the male (median NRS 10 [9-10] versus 8 [8-10], p<0.001) (Fig. 3).

Fig. 3
figure 3

Pain in function of the gender. This figure shows the pain score on the numeric rating scale (NRS) on the vertical axis and the frequencies of pain in % for men and women on the horizontal axis

Satisfaction with esketamine analgesia decreased significantly (p<0.001) in this age group (Table 2).

Table 2 Patient satisfaction

Discussion

Good patient perception and low side effects of analgesia administration in a prehospital setting are very important for patient safety and satisfaction for patients and provider with analgesia. In the present study, analgesia with low-dose esketamine was associated with low side effects and high patient satisfaction in several indications.

Side effects

Patients interviewed reported analgesia with generally few side effects, never reported unbearable side effects, but borderline manageable nausea in 2%. The literature reports nausea with ketamine in approximately 1% of patients [6]. However, dosage is not well known, nor is patient age. It is also not possible to deduce from patient feedback if the nausea was preexisting or a result of analgesia. Influence of distance and duration of transport needs to be discussed, including "backward" position. Similarly, anxiety may have been due to the emergency, rather than the analgesia.

The second borderline tolerable side effect was "dreams" but not nightmares at 0.8%. The distinction was made between positive and negative "dreams". The classification used shows a weakness because the interpretation of "borderline tolerable dreams" is somewhat difficult. Ketamine in particular has been reported to cause frequent psychic reactions [21]. However, it seems difficult to predict which patients are more likely to experience neuropsychiatric side effects, which can range from dysphoria and vivid hallucinations to agitation [6, 22]. The reported rates vary from 5 to 30% [21]. In our study, with the lower side effect of low-dose esketemine compared to ketamine, negative dreams occurred in less than 3% and were also described as "tolerable". In contrast, motor agitation, which was well tolerated, was reported in 25% of patients. Benzodiazepines are usually recommended in advance to reduce psychomotor reactions [21]. However, studies indicate that psychogenic effects occur only during the ketamine offset phase [23,24,25,26]. Interestingly, also the package information leaflet for esketamine (Inresa) states that "the risk of psychiatric reactions on awakening from anesthesia may be greatly reduced by combination with a benzodiazepine", suggesting that this phenomenon may be related to the offset phase and may not be equally pronounced and thus relevant to therapy [27]. Thus, it is debatable whether benzodiazepine should be routinely added to low-dose esketamine or selectively added as needed.

We found also that older patients reported significantly more side effects than younger patients. Additionally, patients in the same subgroup (≥80 years) were significantly more dissatisfied than others, but this is an extremely relevant point for emergency medicine. There are limited data on ketamine in the context of analgesia in geriatric patients. A study comparing an intravenous subdissociative dose of ketamine with morphine for analgesia in geriatric patients showed comparable analgesia with higher rates of psychoperceptual side effects [28]. A slower metabolism in elderly patients was discussed [29]. A study of low-dose esketamine for induction of anesthesia in elderly patients undergoing knee arthroplasty again showed no adverse events in the recovery period [30].

Indication

The indication for esketamine, or ketamine, is often associated with prehospital trauma pain or analgesia and anesthesia of polytrauma [31, 32]. Ketamine is fast-acting, easily controlled, and has primarily beneficial effects on the cardiovascular system with the consequent property of supporting some circulatory stability, which is countered by increased myocardial oxygen consumption. However, the clinical use of (es)ketamine is much broader: (es)ketamine can be found in the entire perioperative field, including regional anesthesia for caesarean section, but also, for example, breakthrough pain in herpes zoster, palliative situations [33,34,35]. In pediatric emergency analgesia, it offers a wide range of application options, with intranasal use [27]. Esketamine currently plays a minor role in emergency departments, although low-dose ketamine, also in the form of ketamine infusion, is becoming increasingly popular [36]. Ultimately, (es)ketamine can be used for pain that is difficult to relieve with conventional medications, taking into account contraindications [37].

However, the indications for analgesia in the present study are interpreted by the patients. Injuries, without reference to the diagnoses that are usually not known with certainty in the prehospital setting, are also relatively well reflected as some indications by patients. Some indications are less plausible. For example, the indication of dyspnea was reported by 6% (n=5), but it is not possible to determine what might have caused the dyspnea, such as thoracic trauma, because there is no link to the case documentation.

Patient satisfaction

When gender was compared with the mean pain reported on arrival at the EMS, significantly more women reported severe or very severe pain. This result is unadjusted and comes from a small number of cases, but the literature also shows that women have more severe pain than men [38]. Reasons for this include biological and psychosocial processes but also stereotypical gender roles [39]. However, this may become more important in the future, both in terms of pain assessment and analgesia concepts.

It was expected that pain experience would correlate with increasing age or life experience, and this is significantly reflected. The hypothesis that patients with low pain experience might rate their pain higher than patients with high pain experience could not be confirmed here. This might have required a different study design and a larger sample size.

Limitations

The main limitation of this study is due to the chosen methodology and lack of linkage between patient feedback and operative documentation. The authors are aware of this, as well as limitations due to the sample size and the study’s descriptive nature. As such, the results are not necessarily generalizable, but represent an insight into the findings of the collective studied.

Although the patients' feedback sounds largely plausible, it must be taken into account that the patients were given a sedative for each analgesia and may not remember it correctly. Approximately 30% of respondents were assisted in completing the questionnaire, which can introduce bias. Although a dose of 1 mg of midazolam is not considered high, it may still impact the experience.

The time between the event and questionnaire delivery was 10 days. Some feedback criticized that the period was too long, while other feedback found it to be too short. Theoretically, a distortion due to positive event recall bias could be discussed, influencing the perception of care and side effects.

What the survey does not show are critical events such as respiratory depression and similar medical issues. No adverse events were seen in operational documentation during the data extraction review.

Conclusion

Thus, the use of low-dose esketamine for pain management in the prehospital setting appears to be associated with very high patient satisfaction, with few reported side effects. Also, esketamine appears to be satisfactory in all age groups in the studied collective; however, from this, patients over 80 years of age should be treated more cautiously to minimize side effects while achieving adequate analgesia. In this age group, other treatment options (e.g., opioids, but also inhaled analgesics) may have better treatment pathways in the elderly.

Availability of data and materials

The data sets analyzed in the current study are available for on-site review upon request from the corresponding author.

Abbreviations

EMS:

Emergency Medical Service

NRS:

Nummeric Rating Scale

PROM:

Patient-reported Outcome Measure

1. References

  1. Häske D, Böttiger BW, Bouillon B, Fischer M, Gaier G, Gliwitzky B, et al. Analgesie bei traumapatienten in der notfallmedizin. Notfall Rettungsmed. 2019;22:537–52. https://0-doi-org.brum.beds.ac.uk/10.1007/s10049-019-00629-y.

    Article  Google Scholar 

  2. Sander H, Matschuck G, Möckel M, Nübling M, Gnirke A. Patientenzufriedenheit nach anwendung eines standardisierten analgesieverfahrens durch rettungsfachpersonal – eine beobachtungsstudie. Der Notarzt. 2022;38:130–7. https://0-doi-org.brum.beds.ac.uk/10.1055/a-1642-8583.

    Article  Google Scholar 

  3. Hämäläinen J, Kvist T, Kankkunen P. Acute pain assessment inadequacy in the emergency department: patients’ perspective. J Patient Exp. 2022;9: 23743735211049677. https://0-doi-org.brum.beds.ac.uk/10.1177/23743735211049677.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Supples MW, Vaizer J, Liao M, Arkins T, Lardaro TA, Faris G, et al. Patient demographics are Associated with differences in Prehospital Pain Management among Trauma patients. Prehosp Emerg Care. 2022:1–6. https://0-doi-org.brum.beds.ac.uk/10.1080/10903127.2022.2132565.

  5. Whitley GA, Wijegoonewardene N, Nelson D, Curtis F, Ortega M, Siriwardena AN. Patient, family member, and ambulance staff experiences of prehospital acute pain management in adults: a systematic review and meta-synthesis. J Am Coll Emerg Physicians Open. 2023;4:e12940. https://0-doi-org.brum.beds.ac.uk/10.1002/emp2.12940.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Häske D, Böttiger BW, Bouillon B, Fischer M, Gaier G, Gliwitzky B, et al. Analgesia in patients with trauma in Emergency Medicine: a systematic review and meta-analysis. Dtsch Arztebl Int. 2017;114:785–92. https://0-doi-org.brum.beds.ac.uk/10.3238/arztebl.2017.0785.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Carstens E, Eismann H, Flentje M, Albers T, Sieg L. Medikamentöse Ausstattung arztbesetzter rettungsmittel – ist eine präklinische Therapie Nach Aktuellen Leitlinien möglich? [Stocked medications in emergency medical service vehicles staffed by physicians-is prehospital treatment according to current guidelines possible?]. Notfall Rettungsmed. 2022:1–10. https://0-doi-org.brum.beds.ac.uk/10.1007/s10049-022-01036-6.

  8. Trimmel H, Egger A, Doppler R, Pimiskern M, Voelckel WG. Usability and effectiveness of inhaled methoxyflurane for prehospital analgesia - a prospective, observational study. BMC Emerg Med. 2022;22:8. https://0-doi-org.brum.beds.ac.uk/10.1186/s12873-021-00565-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Dittmar MS, Kneißl K, Schlickeisen J, Lamprecht C, Kraus M, Glaser C, et al. Eigenständige analgesie mit piritramid durch notfallsanitäter – retrospektive auswertung der elektronischen einsatzdokumentation. Notfall Rettungsmed. 2023. https://0-doi-org.brum.beds.ac.uk/10.1007/s10049-023-01156-7.

    Article  Google Scholar 

  10. Sharma A, Minh Duc NT, Luu Lam Thang T, Nam NH, Ng SJ, Abbas KS, et al. A Consensus-based checklist for reporting of Survey studies (CROSS). J Gen Intern Med. 2021;36:3179–87. https://0-doi-org.brum.beds.ac.uk/10.1007/s11606-021-06737-1.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Häske D, Schempf B, Gaier G, Niederberger C. Prähospitale Analgosedierung Durch Rettungsassistenten: Effektivität Und Prozessqualität Unter ärztlicher Supervision. [Prehospital analgesia performed by paramedics: quality in processes and effects under medical supervision]. Anaesthesist. 2014;63:209–16. https://0-doi-org.brum.beds.ac.uk/10.1007/s00101-014-2301-3.

    Article  CAS  PubMed  Google Scholar 

  12. Schempf B, Casu S, Häske D. Prähospitale Analgosedierung durch Notärzte und Rettungsassistenten : Vergleich der Effektivität: Vergleich der Effektivitat. [Prehospital analgesia by emergency physicians and paramedics : Comparison of effectiveness]. Anaesthesist. 2017;66:325–32. https://0-doi-org.brum.beds.ac.uk/10.1007/s00101-017-0288-2.

    Article  CAS  PubMed  Google Scholar 

  13. Häske D, Dorau W, Heinemann N, Eppler F, Schopp T, Schempf B. Efficacy and safety in ketamine-guided prehospital analgesia for abdominal pain. Intern Emerg Med. 2022;17:2291–7. https://0-doi-org.brum.beds.ac.uk/10.1007/s11739-022-03091-w.

    Article  PubMed  Google Scholar 

  14. Schempf B, Dorau W, Eppler F, Heinemann N, Metzger M, Häske D. Best practice – beispiel für ein Notfallsanitäterkompetenzsystem Im Rahmen Der Anwender- Und Patientensicherheit: Der Reutlinger Weg. [Best practice-example of a paramedic competence system in the context of user and patient safety: the Reutlinger Weg]. Notfall Rettungsmed. 2022;26:439–50. https://0-doi-org.brum.beds.ac.uk/10.1007/s10049-022-00989-y.

    Article  Google Scholar 

  15. Maurischat C, Härter M, Bengel J. Der Freiburger Fragebogen - Stadien Der Bewältigung Chronischer Schmerzen (FF-STABS). Diagnostica. 2002;48:190–9. https://0-doi-org.brum.beds.ac.uk/10.1026//0012-1924.48.4.190.

    Article  Google Scholar 

  16. Deutsche Schmerzgesellschaft e.V. Deutscher Schmerzfragebogen. 2023. https://www.schmerzgesellschaft.de/schmerzfragebogen. Accessed 20 Apr 2023.

  17. Miernik A, Farin E, Kuehhas FE, Karcz WK, Keck T, Wengenmayer T, et al. Freiburger Index für Patientenzufriedenheit: Interdisziplinäre Validierung eines psychometrischen Instrumentes Zur Erfassung Behandlungsbezogener Patientenzufriedenheit. [Freiburg index of patient satisfaction: interdisciplinary validation of a new psychometric questionnaire to describe treatment-related patient satisfaction]. Chirurg. 2013;84:511–8. https://0-doi-org.brum.beds.ac.uk/10.1007/s00104-012-2441-4.

    Article  CAS  PubMed  Google Scholar 

  18. Schmidt J, Wittmann WW. ZUF-8. Fragebogen zur Messung der Patientenzufriedenheit. In: Brähler E, Schumacher J, Strauß B, editors. Diagnostische Verfahren in der Psychotherapie. Hogrefe; 2002. p. 392-96. 

  19. Neumayr A, Gnirke A, Schaeuble JC, Ganter MT, Sparr H, Zoll A, et al. Patient satisfaction in out-of-hospital emergency care: a multicentre survey. Eur J Emerg Med. 2016;23:370–4. https://0-doi-org.brum.beds.ac.uk/10.1097/MEJ.0000000000000264.

    Article  PubMed  Google Scholar 

  20. Sander H, Matschuck G, Möckel M, Nübling M, Gnirke A. Entwicklung eines standardisierten Fragebogens für die präklinische Analgesie Zur Messung Der Patientenzufriedenheit Nach Anwendung eines Analgesieverfahrens Durch Rettungsfachpersonal. Der Notarzt. 2023;39:75–82. https://0-doi-org.brum.beds.ac.uk/10.1055/a-1823-0594.

    Article  Google Scholar 

  21. Moy RJ, Le Clerc S. Ketamine in prehospital analgesia and anaesthesia. Trends in Anaesthesia and Critical Care. 2011;1:243–5. https://0-doi-org.brum.beds.ac.uk/10.1016/j.tacc.2011.08.002.

    Article  Google Scholar 

  22. Quirk K, Smith MA. Risk factors for the development of neuropsychiatric adverse effects in ketamine-treated Pain. J Pain Palliat Care Pharmacother. 2022;36:88–94. https://0-doi-org.brum.beds.ac.uk/10.1080/15360288.2022.2066745.

    Article  CAS  PubMed  Google Scholar 

  23. American College of Emergency Physicians ACEP. Out-of-hospital use of Analgesia and Sedation. Ann Emerg Med. 2016;67:305–6. https://0-doi-org.brum.beds.ac.uk/10.1016/j.annemergmed.2015.12.014.

    Article  Google Scholar 

  24. Conway A, Rolley J, Sutherland JR. Midazolam for sedation before procedures. Cochrane Database Syst Rev. 2016;2016:CD009491. https://0-doi-org.brum.beds.ac.uk/10.1002/14651858.CD009491.pub2.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Perumal DK, Adhimoolam M, Selvaraj N, Lazarus SP, Mohammed MAR. Midazolam premedication for ketamine-induced emergence phenomenon: a prospective observational study. J Res Pharm Pract. 2015;4:89–93. https://0-doi-org.brum.beds.ac.uk/10.4103/2279-042X.155758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wathen JE, Roback MG, Mackenzie T, Bothner JP. Does midazolam alter the clinical effects of intravenous ketamine sedation in children? A double-blind, randomized, controlled, emergency department trial. Ann Emerg Med. 2000;36:579–88. https://0-doi-org.brum.beds.ac.uk/10.1067/mem.2000.111131.

    Article  CAS  PubMed  Google Scholar 

  27. Gliwitzky B, Olivieri M, Bathe J, Landsleitner B, Hoffmann F, Hossfeld B, Häske D. Intranasale Analgesie Bei Säuglingen Und Kleinkindern. Notfall Rettungsmed. 2022;25:53–7. https://0-doi-org.brum.beds.ac.uk/10.1007/s10049-021-00958-x.

    Article  Google Scholar 

  28. Motov S, Mann S, Drapkin J, Butt M, Likourezos A, Yetter E, et al. Intravenous subdissociative-dose ketamine versus morphine for acute geriatric pain in the Emergency Department: a randomized controlled trial. Am J Emerg Med. 2019;37:220–7. https://0-doi-org.brum.beds.ac.uk/10.1016/j.ajem.2018.05.030.

    Article  PubMed  Google Scholar 

  29. Riccardi A, Guarino M, Serra S, Spampinato MD, Vanni S, Shiffer D, et al. Narrative review: low-dose ketamine for Pain Management. J Clin Med. 2023. https://0-doi-org.brum.beds.ac.uk/10.3390/jcm12093256.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Li J, Wang Z, Wang A, Wang Z. Clinical effects of low-dose esketamine for anaesthesia induction in the elderly: a randomized controlled trial. J Clin Pharm Ther. 2022;47:759–66. https://0-doi-org.brum.beds.ac.uk/10.1111/jcpt.13604.

    Article  CAS  PubMed  Google Scholar 

  31. Feth M, Eimer C, Grübl T, Kulla M, Hossfeld B. Update zur prähospitalen Versorgung Polytraumatisierter Patienten. Notfall Rettungsmed. 2023;26:243–50. https://0-doi-org.brum.beds.ac.uk/10.1007/s10049-023-01155-8.

    Article  Google Scholar 

  32. Michael M, Häske D, Hossfeld B, Bohn A, Bernhard M. Analgesie, Sedierung Und Anästhesie in Der Notfallmedizin. Anästhesiologie & Intensivmedizin. 2020;61:51–65.

    Google Scholar 

  33. Tang J, Zhang E, Huang B, Fei Y, Yao M. Efficacy of patient-controlled intravenous analgesia with Esketamine for Herpes Zoster Associated with breakthrough Pain. Pain Physician. 2023;26:299–306.

    PubMed  Google Scholar 

  34. Weixler D, Hartmann W. S-+-Ketamin i.v. Zur Behandlung Von Viszeralem Schmerz in Der Finalphase. [Intravenous S-+-ketamine for treatment of visceral pain in the final phase]. Wien Med Wochenschr. 2006;156:318–23. https://0-doi-org.brum.beds.ac.uk/10.1007/s10354-006-0298-1.

    Article  PubMed  Google Scholar 

  35. Wang X, Lin C, Lan L, Liu J. Perioperative intravenous S-ketamine for acute postoperative pain in adults: a systematic review and meta-analysis. J Clin Anesth. 2021;68: 110071. https://0-doi-org.brum.beds.ac.uk/10.1016/j.jclinane.2020.110071.

    Article  CAS  PubMed  Google Scholar 

  36. Balzer N, McLeod SL, Walsh C, Grewal K. Low-dose ketamine for Acute Pain Control in the Emergency Department: a systematic review and Meta-analysis. Acad Emerg Med. 2021;28:444–54. https://0-doi-org.brum.beds.ac.uk/10.1111/acem.14159.

    Article  PubMed  Google Scholar 

  37. Zhang X-X, Zhang N-X, Liu D-X, Ding J, Zhang Y-N, Zhu Z-Q. Research advances in the clinical application of esketamine. Ibrain. 2022;8:55–67. https://0-doi-org.brum.beds.ac.uk/10.1002/ibra.12019.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10:447–85. https://0-doi-org.brum.beds.ac.uk/10.1016/j.jpain.2008.12.001.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth. 2013;111:52–8. https://0-doi-org.brum.beds.ac.uk/10.1093/bja/aet127.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank our paramedics, who consistently put the patient first while doing an excellent job.

Funding

Open Access funding enabled and organized by Projekt DEAL. The study has no financial support.

Author information

Authors and Affiliations

Authors

Contributions

DH led the overall project, FE and NH organized the implementation, and DH, NH, and BS were responsible for quality assurance. DH drafted the script and performed the statistical analyses. NH, FE, and BS added further discussion points. All authors read the manuscript and agreed to publication.

Corresponding author

Correspondence to David Häske.

Ethics declarations

Ethics approval and consent to participate

This study was conducted in accordance with applicable laws and guidelines. The data collection is based on the nationwide legal obligation for quality assurance in EMS, including personal data. Written informed consent was obtained from all the participants involved in the study and for minors, informed consent was obtained from parents or guardians. There were no disadvantages for non-participation. Data collection for the study was also anonymous. Compliance with the legal requirements of the European General Data Protection Regulation was reviewed and approved by the data protection officer. Ethical review was performed by the Ethics Committee of the Medical Faculty of the Eberhard Karls University and the University Hospital Tübingen (No. 825/2022BO2), which had no objections and approved the study.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Häske, D., Eppler, F., Heinemann, N. et al. Patient-reported side effects and satisfaction of pre-hospital analgesia with low-dose esketamine: a cross-sectional study. BMC Emerg Med 23, 130 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12873-023-00898-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12873-023-00898-4

Keywords